Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Age may be a driver of therapeutic testosterone level in transgender men

Publish date:: May 13, 2019

Key clinical point: The testosterone dose needed for hormonal therapy in transgender men may decrease with older age.

Major finding: Adjusted for BMI, the dose of testosterone decreased by 2.0 mg for every one-year increase in age.

Study details: A retrospective analysis of 40 transgender men.

Disclosures: The researchers reported having no financial conflicts.

Citation:

REPORTING FROM AACE 2019

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Transgender Health

Don’t miss cardiovascular risk factors in transgender patients,

Hormone therapy boosts body image in transgender youth,

Gender pronouns in EMR preferred by many gender nonconforming teens,

Pubertal suppression in adolescence cuts risk of later suicidal ideation in transgender people,

Semen cryopreservation viable for young transgender patients in small study,